drugset / Trial / NCT00255476
The IRESSA Novel Head and Neck Chemotherapy Evaluation Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the objectie tumour response rate between the cisplatin/5FU and cisplatin/5FU plus ZD1839 combination
Timeline
- Start
- 2004-02
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | — | — |
| Background | 5-flourouracil | Unknown | — | — |
| Background | Cisplatin | Other / unclassified | — | — |